Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

fresenius kabi usa, llc - choriogonadotropin alfa (unii: 6413w06wr3) (choriogonadotropin alfa - unii:6413w06wr3) - choriogonadotropin alfa 10000 [usp'u] in 10 ml - hcg has not been demonstrated to be effective adjunctive therapy in the treatment of obesity.  there is no substantial evidence that it increases weight loss beyond that resulting from caloric restriction, that it causes a more attractive or ‘‘normal’’ distribution of fat, or that it decreases the hunger and discomfort associated with calorie-restricted diets. - prepubertal cryptorchidism not due to anatomical obstruction.  in general, hcg is thought to induce testicular descent in situations when descent would have occurred at puberty.  hcg thus may help predict whether or not orchiopexy will be needed in the future.  although, in some cases, descent following hcg administration is permanent, in most cases, the response is temporary.  therapy is usually instituted between the ages four and nine. - selected cases of hypogonadotropic hypogonadism (hypogonadism secondary to a pituitary deficiency) in males. - induction of ovulation and pregnancy in the anovulatory, infertile woman in whom the cause of anovulati

Kanada - inglise - Health Canada

fresenius kabi canada ltd - chorionic gonadotropin - powder for solution - 10000unit - chorionic gonadotropin 10000unit - gonadotropins and antigonadotropins

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

apotheca company - human chorionic gonadotropin (unii: 20ed16gheb) (human chorionic gonadotropin - unii:20ed16gheb) - human chorionic gonadotropin 60 [hp_x] in 1 ml - indications:   supports weight loss by facilitating hormone functions and temporarily decreasing appetite. indications:   supports weight loss by facilitating hormone functions and temporarily decreasing appetite.

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

ax pharmaceutical corp - human chorionic gonadotropin (unii: 20ed16gheb) (chorionic gonadotropin - unii:20ed16gheb) - human chorionic gonadotropin 990000 [iu] in 1000000 [iu]

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

ferring pharmaceuticals inc. - chorionic gonadotropin (unii: 20ed16gheb) (chorionic gonadotropin - unii:20ed16gheb) - gonadotrophin, chorionic 10000 [usp'u] - hcg has not been demonstrated to be effective adjunctive therapy in the treatment of obesity. there is no substantial evidence that it increases weight loss beyond that resulting from caloric restriction, that it causes a more attractive or "normal" distribution of fat, or that it decreases the hunger and discomfort associated with calorie-restricted diets. - prepubertal cryptorchidism not due to anatomic obstruction. in general, hcg is thought to induce testicular descent in situations when descent would have occurred at puberty. hcg thus may help to predict whether or not orchiopexy will be needed in the future. although, in some cases, descent following hcg administration is permanent, in most cases the response is temporary. therapy is usually instituted between the ages of 4 and 9. - selected cases of hypogonadotropic hypogonadism (hypogonadism secondary to a pituitary deficiency) in males. - induction of ovulation and pregnancy in the anovulatory, infertile woman in whom the cause of anovulation is seco

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

apotheca company - human chorionic gonadotropin (unii: 20ed16gheb) (human chorionic gonadotropin - unii:20ed16gheb) - human chorionic gonadotropin 34 [hp_c] in 1 ml - indications:   supports weight loss by regulating male and female hormone functions and also by suppressing ravenous appetite. indications: supports weight loss by regulating male and female hormone functions and also by suppressing ravenous appetite.

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

apotheca company - human chorionic gonadotropin (unii: 20ed16gheb) (human chorionic gonadotropin - unii:20ed16gheb) - human chorionic gonadotropin 60 [hp_x] in 1 ml

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

apotheca company - human chorionic gonadotropin (unii: 20ed16gheb) (human chorionic gonadotropin - unii:20ed16gheb) - human chorionic gonadotropin 200 [hp_c] in 1 ml - indications:   supports weight loss by regulating male and female hormone functions and also suppressing ravenous appetite.

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

abco laboratories, inc. - gonadotrophin, chorionic (unii: 20ed16gheb) (gonadotrophin, chorionic - unii:20ed16gheb), garcinia cambogia fruit (unii: d0qji8uqvr) (garcinia cambogia fruit - unii:d0qji8uqvr), bos taurus hypothalamus (unii: s6g2nlh4y7) (bos taurus hypothalamus - unii:s6g2nlh4y7), bos taurus brain (unii: a1yee2db8z) (bos taurus brain - unii:a1yee2db8z), pork liver (unii: 6ec706hi7f) (pork liver - unii:6ec706hi7f), methylcobalamin (unii: br1sn1js2w) (methylcobalamin - unii:br1sn1js2w), sus scrofa pancreas (unii: 9y3j3 - gonadotrophin, chorionic 12 [hp_x] in 60 ml - - provides homeopathic support for temporary relief of symptioms related to obesity, weight gain, appetite support, detoxification, regulation of fat metabolism, headache, - fatigue and irritability, while following a proper diet and exercise program. - provides homeopathic support for temporary relief of symptioms related to obesity, weight gain, appetite support, detoxification, regulation of fat metabolism, headache, - fatigue and irritability, while following a proper diet and exercise program.

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

emd serono, inc. - choriogonadotropin alfa (unii: 6413w06wr3) (choriogonadotropin alfa - unii:6413w06wr3) - choriogonadotropin alfa 250 ug in 0.5 ml - ovidrel® prefilled syringe (choriogonadotropin alfa injection) is indicated for the induction of final follicular maturation and early luteinization in infertile women who have undergone pituitary desensitization and who have been appropriately pretreated with follicle stimulating hormones as part of an assisted reproductive technology (art) program such as in vitro fertilization and embryo transfer. ovidrel® prefilled syringe is also indicated for the induction of ovulation (oi) and pregnancy in anovulatory infertile patients in whom the cause of infertility is functional and not due to primary ovarian failure. - before treatment with gonadotropins is instituted, a thorough gynecologic and endocrinologic evaluation must be performed. this should include an assessment of pelvic anatomy. patients with tubal obstruction should receive ovidrel® prefilled syringe only if enrolled in an in vitro fertilization program. - primary ovarian failure should be excluded by the determination of gonadotropin levels. - appropriate evaluation should be performed to exclude pregnancy. - patients in later reproductive life have a greater predisposition to endometrial carcinoma as well as a higher incidence of anovulatory disorders. a thorough diagnostic evaluation should always be performed in patients who demonstrate abnormal uterine bleeding or other signs of endometrial abnormalities before starting fsh and ovidrel® prefilled syringe therapy. - evaluation of the partner's fertility potential should be included in the initial evaluation. ovidrel® prefilled syringe (choriogonadotropin alfa injection) is contraindicated in women who exhibit: - prior hypersensitivity to hcg preparations or one of their excipients. - primary ovarian failure. - uncontrolled thyroid or adrenal dysfunction. - an uncontrolled organic intracranial lesion such as a pituitary tumor. - abnormal uterine bleeding of undetermined origin (see "selection of patients" ). - ovarian cyst or enlargement of undetermined origin (see "selection of patients" ). - sex hormone dependent tumors of the reproductive tract and accessory organs. - pregnancy.